Downloaded from https://www.everyspec.com present for an extended period of time, the physician may refer the Soldier to an MEB if the Soldier does not meet medical retention standards. DA Form 3349 will be completed outlining specific limitations. 8–26. Cardiovascular Screening Program (CVSP) a. The CVSP is required as part of the periodic health assessment for all the Active Army, ARNG/ARNGUS, and USAR (Selective Reserve) Soldiers age 40 and older. Cardiovascular screening will be done every five years unless otherwise clinically indicated. The CVSP begins with a Level 1 evaluation. b.
The Level I cardiovascular evaluation is conducted to determine the cardiovascular risk based on the presence of independent risk factors identified. The Level I evaluation will consist of:— (1) Medical history to include family and smoking history. (2) Medical records review. (3) Blood pressure. (4) Fasting lipid profile, including total cholesterol, LDL, HDL, and triglycerides. (5) Electrocardiogram (ECG). (6) Fasting blood glucose. (7) Height and weight. (8) Calculation of a Framingham ten-year risk percentage. The National Cholesterol Education Program offers an online tool for calculating the Framingham ten-year coronary heart disease (CHD) risks. The site is:
http://hin.nhlbi.n- ih.gov/atpiii/calculator.asp?usertype=prof and a downloadable version is at http://hin.nhlbi.nih.gov/atpii/riskcalc.htm. MEDPROS Framingham Tool (when available) may also be used. c. Those Soldiers with the following findings on the ECG will require a Level II screening independent of the Framingham risk score: (1) Any supraventricular tachycardia (3 or more beats at a rate greater than 100) to include atrial fibrillation/flutter, multifocal atrial tachycardia, junctional tachycardia, and persistent sinus tachycardia.
(2) Conduction disturbances of left bundle branch block (QRS duration more than 120 msec), Mobitz type II second degree atrioventricular (AV) block, and third degree AV block. (3) Short PR interval (PR interval less than 120 milliseconds (msec) in all 12 leads). (4) Sinus pause or asystole greater than 2 seconds in duration. d. For those Soldiers with Framingham ten-year risk scores of between 10% and 15%, they will be referred to their primary care provider (PCM) for cardiac risk reduction treatment and education.
The purpose of the medical referral is to confirm the presence of modifiable coronary risk factors and to advise and initiate medically appropriate treatments with the intent to modify cardiovascular risk. PCMs may further characterize risk by measuring C-Reactive Protein (CRP) and assessing for metabolic syndrome. If CRP is elevated or metabolic syndrome is present, the PCM should consider referring these Soldiers for Level II evaluation and reevaluating them annually.
(1) Primary care providers should use the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) or later version, the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, and other appropriate clinical practice guidelines. (2) If the Soldier is already under treatment and the Framingham ten-year risk score is less than 10% while on treatment, a separate referral for the purpose of the CVSP is not required. The medical records need to document the medical history, what treatment the Soldier is currently on, and where the Soldier is obtaining the treatment.
If the risk score is between 10% and 15%, the Soldier will be referred back to his or her PCM for further care. (3) Soldiers with hypertension should have a treatment plan for controlling his/her blood pressure documented by a PCM. e. RC Soldiers will be referred to their own medical provider outside of the military system for any further follow- up evaluation, treatment, and so forth. The Soldier will provide copies of any records (pertaining to their medical management) from their civilian medical provider for inclusion in their military medical health record. f.
For those Soldiers with a Framingham ten-year risk score of greater than 15%, a history of coronary heart disease (CHD) or a CHD-risk equivalent (peripheral arterial disease, abdominal aortic aneurysm, symptomatic carotid artery disease and diabetes), they must undergo a Level II evaluation. The Level II evaluation will consist of non-invasive testing using one (or more, when medically indicated) of the following tests: (1) The Graded Exercise Stress Test (GXT; Bruce or modified Bruce protocols).
If, during the GXT, blood pressure increases to greater than 200 mmHg systolic or 100 mmHg diastolic during or after exercise, an echocardiogram is recommended to rule out pathologic ventricular hypertrophy. (2) Myocardial perfusion scintigraphy (thallium, sestamibi). (3) Exercise and/or pharmacologic stress echocardiography. (4) Once a Soldier has been cleared based on a Level II evaluation, reevaluation will be specified by the consulted cardiologist (or primary care doctor credentialed to perform/interpret the Level II test). Typically, such Soldiers need reevaluation in 3 years; and sooner if they develop new symptoms or an increase in cardiac risk factors.
(5) Soldiers with metabolic syndrome (three or more of the following: waist > 40 inches for males and > 35 inches 94 AR 40–501 • 14 December 2007